Looking at the universe of stocks we cover at Dividend Channel, on 1/30/24, West Pharmaceutical Services, Inc. (Symbol: WST), Virtus Investment Partners Inc (Symbol: VRTS), and Agree Realty Corp. (Symbol: ADC). ) will all trade ex-dividend for their respective upcoming dividends. West Pharmaceutical Services, Inc. will pay its quarterly dividend of $0.20 on 2/7/24, Virtus Investment Partners Inc will pay its quarterly dividend of $1.90 on 02/15/24, and Agree Realty Corp. will pay its monthly dividend of $0.247. on 2/14/24. As a percentage of WST’s recent share price of $354.22, this dividend works out to approximately 0.06%, so look for shares of West Pharmaceutical Services, Inc. to trade 0.06% lower – all else being equal – when WST shares open for trading at 1. /30/24. Similarly, investors should look for VRTS to open 0.78% lower in price and for ADC to open 0.41% lower, all else being equal.
Below are dividend history charts for WST, VRTS and ADC, showing historical dividends before the most recently declared.
West Pharmaceutical Services, Inc. (Symbol: WST):
Virtus Investment Partners Inc (Symbol: VRTS):
Agree Realty Corp. (Symbol: ADC):
In general, dividends are not always predictable, following the ups and downs of company profits over time. Therefore, a good first due diligence step to form an expectation of annual performance going forward is to look at the history above, for a sense of stability over time. This can help judge whether these companies’ most recent dividends are likely to continue. If they continue, the current estimated returns on an annualized basis would be 0.23% for West Pharmaceutical Services, Inc., 3.11% for Virtus Investment Partners Inc, and 4.97% for Agree Realty Corp.
In Friday trading, the shares of West Pharmaceutical Services, Inc. is up about 1.6%, shares of Virtus Investment Partners Inc are up about 1.5%, and shares of Agree Realty Corp. rises about 1% in the day.
See also:
• LMNL YTD Return
• United Airlines Holdings Stock Split History
• ETFs Holding DAL
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.